Predicting future risk of asthma exacerbations using individual conditional probabilities.

BACKGROUND Determination of future risk of exacerbations is a key issue in the management of asthma. We previously developed a method to calculate conditional probabilities (π) of future decreases in lung function by using the daily fluctuations in peak expiratory flow (PEF). OBJECTIVE We aimed to extend calculation of π values to individual patients, validated by using electronically recorded data from 2 past clinical trials. METHODS Twice-daily PEF data were analyzed from 78 patients with severe (study A) and 61 patients with poorly controlled (study B) asthma. For each patient, the π value was calculated from 5000 PEF data points simulated based on the correlation and distribution properties of observed PEF. Given an initial PEF, the π value was defined as the probability of a decrease in PEF to less than 80% of predicted value on 2 consecutive days within a month. These probabilities were then compared with actual occurrences of such events and clinically defined exacerbations within the following month. RESULTS π Values were related to actual occurrences of decreases in PEF (adjusted R(2) > 0.800 for both studies). Every increase of 10% in π value was associated with an odds ratio of having a future exacerbation of 1.24 (95% CI, 1.07-1.43) for study A and 1.13 (95% CI, 1.02-1.26) for study B, with better sensitivity and specificity than clinic-measured FEV(1). CONCLUSION These results from 2 independent datasets with differing asthmatic populations and differing exacerbation criteria provide support that clinically relevant quantification of individual future risk of exacerbations is possible.

[1]  P. J. Barnes,et al.  Global strategy for asthma management and prevention: GINA executive summary , 2008, European Respiratory Journal.

[2]  D. Postma,et al.  Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. The Dutch CNSLD Study Group. , 1991, The American review of respiratory disease.

[3]  P. Phelan,et al.  Predicting the course of asthma in children , 1982, Australian paediatric journal.

[4]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[5]  F. Colardyn,et al.  National Heart, Lung and Blood Institute, National Institutes of Health. International Consensus Report on Diagnosis and Management of Asthma , 1992 .

[6]  N. Thomson,et al.  Identification and management of adults with asthma prone to exacerbations: can we do better? , 2008, BMC pulmonary medicine.

[7]  N. Zamel,et al.  Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. , 2006, Chest.

[8]  C. Jenkins,et al.  Analysis of adherence to peak flow monitoring when recording of data is electronic , 2002, BMJ : British Medical Journal.

[9]  Partridge,et al.  International Consensus Report on Diagnosis and Treatment of Asthma. , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  K. Guntupalli,et al.  Acute severe asthma: recent advances , 2007, Current opinion in pulmonary medicine.

[11]  M. Strippoli,et al.  Fluctuation analysis of lung function as a predictor of long-term response to β2-agonists , 2009, European Respiratory Journal.

[12]  P B Boggs,et al.  Using statistical process control charts for the continual improvement of asthma care. , 1999, The Joint Commission journal on quality improvement.

[13]  Barrett T. Kitch,et al.  FEV(1) is associated with risk of asthma attacks in a pediatric population. , 2001, The Journal of allergy and clinical immunology.

[14]  F. Wamboldt,et al.  History of serious asthma exacerbations should be included in guidelines of asthma severity. , 2007, The Journal of allergy and clinical immunology.

[15]  A David Paltiel,et al.  A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up. , 2004, Chest.

[16]  C. Jenkins,et al.  Optimal asthma control, starting with high doses of inhaled budesonide. , 2000, The European respiratory journal.

[17]  John Wlodarczyk,et al.  Using Quality-Control Analysis of Peak Expiratory Flow Recordings To Guide Therapy for Asthma , 1995, Annals of Internal Medicine.

[18]  B. Suki,et al.  Correlation properties of tidal volume and end-tidal O2 and CO2 concentrations in healthy infants. , 2002, Journal of applied physiology.

[19]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[20]  Christine Jenkins,et al.  Overall asthma control: the relationship between current control and future risk. , 2010, The Journal of allergy and clinical immunology.

[21]  S. Szefler,et al.  Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma. , 2009, The Journal of allergy and clinical immunology.

[22]  Sally E Wenzel,et al.  Recent asthma exacerbations: a key predictor of future exacerbations. , 2007, Respiratory medicine.

[23]  I. Pavord,et al.  A new perspective on concepts of asthma severity and control , 2008, European Respiratory Journal.

[24]  A. Buist,et al.  Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. , 2007, Chest.

[25]  A. Zwinderman,et al.  Risk factors of frequent exacerbations in difficult-to-treat asthma , 2005, European Respiratory Journal.

[26]  H. Reddel.  Peak flow monitoring in clinical practice and clinical asthma trials , 2006, Current opinion in pulmonary medicine.

[27]  W. Tierney,et al.  Assessing symptoms and peak expiratory flow rate as predictors of asthma exacerbations , 2004, Journal of General Internal Medicine.

[28]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[29]  Arnab Majumdar,et al.  Risk of severe asthma episodes predicted from fluctuation analysis of airway function , 2005, Nature.

[30]  J. Brehm,et al.  Risk factors and predictive clinical scores for asthma exacerbations in childhood. , 2010, Chest.

[31]  Gary Iwamoto,et al.  Exhaled Nitric Oxide Predicts Asthma Exacerbation , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[32]  Urs Frey,et al.  Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control , 2008, The Lancet.

[33]  H. Stanley,et al.  Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. , 1995, Chaos.

[34]  S. Holgate,et al.  Variability and lack of predictive ability of asthma end-points in clinical trials , 2002, European Respiratory Journal.

[35]  E. Kerwin,et al.  A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. , 2009, American journal of respiratory and critical care medicine.